UK's NICE Recommends Once-daily LIXIANA® (Edoxaban) for the Treatment and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in Adults

DAIICHI SANKYO EUROPE GmbH [Pressemappe]
Tokyo (ots/PRNewswire) – The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has today recommended a new treatment to help patients suffering from blood clots in the legs and … Lesen Sie hier weiter…